Evaluating the cost-benefit profile of CPI stem cell therapy necessitates a comprehensive perspective. Proponents often emphasize the potential for significant therapeutic benefits, especially in diseases where conventional medications have proven limited. However, crucially important to evaluate the considerable financial investment associated wit